SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-301836
Filing Date
2022-12-09
Accepted
2022-12-09 16:31:13
Documents
13
Period of Report
2022-12-05
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d514100d8k.htm   iXBRL 8-K 38361
2 EX-3.1 d514100dex31.htm EX-3.1 122566
  Complete submission text file 0001193125-22-301836.txt   326292

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA snse-20221205.xsd EX-101.SCH 2844
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE snse-20221205_lab.xml EX-101.LAB 19482
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE snse-20221205_pre.xml EX-101.PRE 12149
7 EXTRACTED XBRL INSTANCE DOCUMENT d514100d8k_htm.xml XML 3644
Mailing Address 620 PROFESSIONAL DRIVE GAITHERSBURG MD 20879
Business Address 620 PROFESSIONAL DRIVE GAITHERSBURG MD 20879 (240) 243-8000
Sensei Biotherapeutics, Inc. (Filer) CIK: 0001829802 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39980 | Film No.: 221455203
SIC: 2834 Pharmaceutical Preparations